Home Cart Sign in  
Chemical Structure| 885704-21-2 Chemical Structure| 885704-21-2

Structure of c-Fms-IN-3
CAS No.: 885704-21-2

Chemical Structure| 885704-21-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

c-FMS inhibitor is a c-Fms kinase inhibitor with a potential as anti-inflammatory agent and antirheumatic agent.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of c-Fms-IN-3

CAS No. :885704-21-2
Formula : C23H30N6O
M.W : 406.52
SMILES Code : O=C(C1=CC(C#N)=CN1)NC2=CC=C(N3CCN(C)CC3)C=C2N4CCC(C)CC4
MDL No. :MFCD22124465

Safety of c-Fms-IN-3

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of c-Fms-IN-3

RTK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03042221 - Recruiting April 30, 2019 United States, Colorado ... More >> University of Colorado, Cancer Center Recruiting Aurora, Colorado, United States, 80045 Contact: Mary K Jackson    303-724-1650    mary.k.jackson@ucdenver.edu    Contact: Terry NG, MD    303-724-2980    terry.ng@ucdenver.edu    Principal Investigator: Terry ng, MD Less <<
NCT02371369 Pigmented Villonodular Synovit... More >>is Giant Cell Tumors of the Tendon Sheath Tenosynovial Giant Cell Tumor Less << Phase 3 Active, not recruiting December 2018 -
NCT01548170 Cancer Phase 1 Completed - Spain ... More >> Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Less <<
NCT03481842 Endometriosis ... More >> Endometriosis Ovary Endometriosis Externa Endometriosis, Rectum Less << Phase 1 Phase 2 Not yet recruiting September 30, 2018 Switzerland ... More >> BioGene Pharmaceutical Ltd. Not yet recruiting Basel, Вâlе, Switzerland, 4057 Contact: J. Łanevska, Dr       jula.edu@yahoo.com Less <<
NCT02880371 Advanced Solid Tumors Phase 1 Phase 2 Recruiting April 2020 United States, California ... More >> UCLA Department of Medicine Recruiting Los Angeles, California, United States, 90095 Contact: Jonathan Goldman, MD    310-829-5471    jwgoldman@mednet.ucla.edu    Principal Investigator: Jonathan Goldman, MD          United States, Colorado University of Colorado Recruiting Aurora, Colorado, United States Contact: Matthew Skoch    720-848-0668    matthew.skoch@ucdenver.edu    Contact: Michelle Carr    720-848-7135    michelle.l2.carr@ucdenver.edu    Principal Investigator: Karl Lewis, M.D.          United States, Florida Hematology Oncology Associates of the Treasure Coast Recruiting Port Saint Lucie, Florida, United States, 34952 Contact: Christine Gerdes, RN    772-408-5158    cgerdes@hemoncfl.com    Principal Investigator: Seth Rosen, MD          United States, Indiana Horizon Oncology Research, Inc. Recruiting Lafayette, Indiana, United States, 47905 Contact: Shelli Fassnacht, LPN    765-446-5111    mfassnacht@horizonbioadvance.com    Principal Investigator: Wael A. Harb, MD          United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Justin Gainor    617-724-4000    jgainor@partners.org    Principal Investigator: Justin Gainor, MD          United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Edgar de la Cruz    313-576-8387    delacruz@karmanos.org    Principal Investigator: Amy Weise, D.O.          United States, Minnesota Regions Hospital Recruiting Saint Paul, Minnesota, United States, 55101 Contact: Angie Martizna    651-254-1698    Angela.Martizna@ParkNicollet.com    Principal Investigator: Arkadiusz Dudek, M.D.          United States, Pennsylvania Penn State Hershey Cancer Institute Recruiting Hershey, Pennsylvania, United States, 17033-0850 Contact: Rebecca Hale, RN    717-531-1003    rhale2@pennstatehealth.psu.edu    Principal Investigator: Diane Hershock, MD          United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact: ASKSarah Line    877-691-7274    asksarah@scresearch.net    Principal Investigator: Melissa Johnson, MD          United States, Texas Texas Oncology, P.A., Sammons Cancer Center Withdrawn Dallas, Texas, United States, 75246 UT Health San Antonio Cancer Center Recruiting San Antonio, Texas, United States, 78229 Contact: Epp Goodwin    210-450-5798    goodwine@uthscsa.edu    Principal Investigator: John Sarantopolous, MD          United States, Utah Utah Cancer Specialists Recruiting Salt Lake City, Utah, United States, 84106 Contact: Johnny Walker    801-281-6864    jwalker@utahcancer.com    Principal Investigator: Justin Call, MD          United States, Washington Northwest Medical Specialties Recruiting Tacoma, Washington, United States, 98405 Contact: CarrieAnn Brown, RN, OCN    253-396-5334       Principal Investigator: Jorge Chaves, MD Less <<
NCT03097601 - Active, not recruiting December 30, 2019 France ... More >> Centre Antoine LACASSAGNE Nice, France, 06189 Less <<
NCT03694977 Gastric Cancer Phase 2 Not yet recruiting December 31, 2019 Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01440959 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul,, Korea, Republic of, 138-736 Less <<
NCT03069469 Advanced Malignant Neoplasm Phase 1 Recruiting August 2019 United States, Colorado ... More >> University of Colorado - Denver Recruiting Denver, Colorado, United States, 80204 Contact: Stephen Leong, MD          United States, Oregon OHSU Recruiting Portland, Oregon, United States, 97239 Contact: Matthew Taylor, MD          United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact: Todd Bauer, MD          Principal Investigator: Todd Bauer, MD Less <<
NCT01440959 - Completed - -
NCT02718911 Solid Tumor Phase 1 Active, not recruiting December 4, 2018 United States, Colorado ... More >> Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Georgia Winship Cancer Center Emory University Atlanta, Georgia, United States, 30322 United States, New York New York University Medical Center New York, New York, United States, 10016 Columbia University College of Phys & Surgeons New York, New York, United States, 10032 United States, Tennessee Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 Belgium Universitair Ziekenhuis Antwerpen Edegem, Belgium, 2650 Universitair Ziekenhuis Gent Gent, Belgium, 9000 GZA St Augustinus Wilrijk, Belgium, 2610 Czechia Masarykuv Onkology Institute Brno, Czech Republic, Czechia, 656 53 Israel Rambam Medical Center Haifa, Israel, 3109601 Hadassah Medical Center Jerusalem, Israel, 9112001 Sheba Medical Center Ramat Gan, Israel, 5262000 Less <<
NCT03153410 Pancreatic Cancer Early Phase 1 Recruiting September 2020 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: Ana DeJesus, MD    443-287-0411    adejesu1@jhmi.edu Less <<
NCT02777710 Colorectal Cancer ... More >> Pancreatic Cancer Metastatic Cancer Advanced Cancer Less << Phase 1 Recruiting June 2019 France ... More >> Centre Léon Bérard Recruiting Lyon, France, 69008 Principal Investigator: Philippe CASSIER, MD          Sub-Investigator: Lauriane EBERST, MD          Sub-Investigator: Catherine TERRET, MD          IUCT-oncopole Recruiting Toulouse, France, 31059 Principal Investigator: Carlos GOMEZ-ROCA, MD          Sub-Investigator: Sarah BETRIAN-LAGARDE, MD          Sub-Investigator: Ewa-Anna COTTURA, MD          Sub-Investigator: Jean-Pierre DELORD, MD          Sub-Investigator: Audrey RABEAU, MD          Sub-Investigator: Thibaud VALENTIN, MD Less <<
NCT01316822 Metastatic Cancer Phase 1 Completed - United States, Tennessee ... More >> Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States, 78229 Less <<
NCT02452424 Melanoma Non-... More >>small Cell Lung Cancer Squamous Cell Carcinoma of the Head and Neck Gastrointestinal Stromal Tumor (GIST) Ovarian Cancer Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> HonorHealth Research Institute Scottsdale, Arizona, United States, 85258 United States, California Marin Cancer Care Greenbrae, California, United States, 94904 Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Missouri Washington University St. Louis Siteman Cancer Center Saint Louis, Missouri, United States, 63130 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, South Carolina Medical University Health Hollings Cancer Center Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States, 37212 United States, Texas South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Less <<
NCT01901666 Chronic Myelogenous Leukemia ... More >> Short Stature Less << Phase 4 Unknown December 2014 India ... More >> Postgraduate Institute of Medical Education and Research Recruiting Chandigarh, UT, India, 160012 Contact: anil bhansali, MBBS,MD,DM    9316977995    anilbhansaliendocrine@rediffmail.com Less <<
NCT03557970 Recurrent Adult Acute Myeloid ... More >>Leukemia Refractory Acute Myeloid Leukemia Less << Phase 2 Not yet recruiting December 30, 2023 United States, Oregon ... More >> OHSU Knight Cancer Institute Not yet recruiting Portland, Oregon, United States, 97239 Contact: Elie Traer, MD    503-494-7999    traere@ohsu.edu    Principal Investigator: Elie Traer, MD          United States, Texas UT Southwestern/Simmons Cancer Center-Dallas Not yet recruiting Dallas, Texas, United States, 75390 Contact: Robert Collins    214-648-3060    robert.collins@utsouthwestern.edu    Sub-Investigator: Robert Collins Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.46mL

0.49mL

0.25mL

12.30mL

2.46mL

1.23mL

24.60mL

4.92mL

2.46mL

References

 

Historical Records

Categories